Fifth Third Wealth Advisors LLC grew its holdings in McKesson Co. (NYSE:MCK – Free Report) by 5.2% within the third quarter, in keeping with its most up-to-date disclosure with the Securities and Alternate Fee (SEC). The institutional investor owned 722 shares of the corporate’s inventory after shopping for a further 36 shares through the quarter. Fifth Third Wealth Advisors LLC’s holdings in McKesson had been value $357,000 as of its most up-to-date SEC submitting.
A number of different massive traders have additionally made adjustments to their positions in MCK. Distillate Capital Companions LLC raised its place in shares of McKesson by 127,542.9% through the 2nd quarter. Distillate Capital Companions LLC now owns 35,740 shares of the corporate’s inventory value $20,874,000 after buying a further 35,712 shares over the last quarter. Chase Funding Counsel Corp lifted its stake in McKesson by 50.8% within the 2nd quarter. Chase Funding Counsel Corp now owns 8,985 shares of the corporate’s inventory value $5,247,000 after buying a further 3,027 shares within the final quarter. Wealthspire Advisors LLC grew its place in shares of McKesson by 8.9% within the second quarter. Wealthspire Advisors LLC now owns 1,623 shares of the corporate’s inventory valued at $948,000 after buying a further 133 shares within the final quarter. Vaughan David Investments LLC IL acquired a brand new place in McKesson through the second quarter value $238,000. Lastly, Newbridge Monetary Providers Group Inc. elevated its stake in shares of McKesson by 2,143.1% within the 2nd quarter. Newbridge Monetary Providers Group Inc. now owns 1,458 shares of the corporate’s inventory value $851,000 after buying a further 1,393 shares over the last quarter. 85.07% of the inventory is owned by institutional traders and hedge funds.
Wall Road Analyst Weigh In
A number of equities analysis analysts just lately issued stories on the inventory. Barclays raised their worth goal on shares of McKesson from $596.00 to $616.00 and gave the inventory an “chubby” score in a analysis report on Thursday, August eighth. Citigroup lifted their worth goal on shares of McKesson from $630.00 to $713.00 and gave the corporate a “purchase” score in a analysis report on Wednesday, November thirteenth. JPMorgan Chase & Co. elevated their worth goal on McKesson from $656.00 to $661.00 and gave the inventory an “chubby” score in a analysis report on Wednesday, August twenty first. Leerink Companions diminished their goal worth on McKesson from $665.00 to $630.00 and set an “outperform” score on the inventory in a analysis report on Monday, October seventh. Lastly, Deutsche Financial institution Aktiengesellschaft reduce their worth goal on McKesson from $623.00 to $579.00 and set a “purchase” score for the corporate in a analysis report on Wednesday, September twenty fifth. Two analysts have rated the inventory with a maintain score, fourteen have assigned a purchase score and one has given a robust purchase score to the inventory. Primarily based on knowledge from MarketBeat, the corporate at present has a median score of “Average Purchase” and a median worth goal of $631.57.
View Our Newest Inventory Evaluation on McKesson
Insiders Place Their Bets
In different McKesson information, CEO Brian S. Tyler offered 3,753 shares of McKesson inventory in a transaction on Thursday, September fifth. The shares had been offered at a median worth of $561.10, for a complete worth of $2,105,808.30. Following the transaction, the chief government officer now instantly owns 78,586 shares within the firm, valued at roughly $44,094,604.60. The commerce was a 4.56 % lower of their possession of the inventory. The transaction was disclosed in a doc filed with the SEC, which will be accessed via this hyperlink. 0.11% of the inventory is at present owned by company insiders.
McKesson Value Efficiency
MCK inventory opened at $628.15 on Friday. The enterprise’s 50-day transferring common is $528.89 and its two-hundred day transferring common is $556.74. The agency has a market capitalization of $79.74 billion, a P/E ratio of 32.53, a P/E/G ratio of 1.33 and a beta of 0.44. McKesson Co. has a 1 yr low of $431.35 and a 1 yr excessive of $637.51.
McKesson (NYSE:MCK – Get Free Report) final introduced its quarterly earnings knowledge on Wednesday, November sixth. The corporate reported $7.07 earnings per share for the quarter, beating analysts’ consensus estimates of $6.88 by $0.19. The enterprise had income of $93.65 billion for the quarter, in comparison with analyst estimates of $89.33 billion. McKesson had a internet margin of 0.77% and a detrimental return on fairness of 207.50%. The corporate’s income was up 21.3% on a year-over-year foundation. Throughout the identical interval final yr, the enterprise earned $6.23 EPS. On common, analysts anticipate that McKesson Co. will put up 32.81 EPS for the present yr.
McKesson Broadcasts Dividend
The enterprise additionally just lately disclosed a quarterly dividend, which can be paid on Thursday, January 2nd. Shareholders of file on Monday, December 2nd can be paid a $0.71 dividend. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.84 annualized dividend and a yield of 0.45%. McKesson’s dividend payout ratio is presently 14.71%.
McKesson Firm Profile
McKesson Company supplies healthcare providers in the US and internationally. It operates via 4 segments: U.S. Pharmaceutical, Prescription Expertise Options (RxTS), Medical-Surgical Options, and Worldwide. The U.S. Pharmaceutical section distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical medication, and different healthcare-related merchandise.
See Additionally
Wish to see what different hedge funds are holding MCK? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Obtain Information & Rankings for McKesson Every day – Enter your e-mail deal with under to obtain a concise each day abstract of the most recent information and analysts’ scores for McKesson and associated firms with MarketBeat.com’s FREE each day e-mail publication.
